OakChart

Cronos Group Inc

CRONHealthcare·Drug Manufacturers - Specialty & Generic·Canada·Small·NASD·Nov 11 • 3:59 PM ET

3.45+0.04 (1.17%)
2026-11-12 06:44 CET
Market cap
1,264.33 USD m
Revenue, TTM
206.20 USD m
Net income, TTM
57.83 USD m
Free cash flow, TTM
64.94 USD m
EPS diluted, TTM
0.15
P/E
22.39
Compare

Price

CRON against its 20, 50 and 200-day averages
2050200beat
2.503.003.502.8M5.7MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CRONclose 3.4520-day 3.3950-day 3.32200-day 2.893.4552w high

11.8% under the 52-week high of 3.91 on 5 Nov 2026. 52-week low 2.28 on 20 Nov 2025. Last 15 sessions, 19.8% high to low

Volume 0.98× normal · the line is the 50-bar volume average

Profile

CRON
52-week range, 72% of the way up
2.283.91

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Stayner, Canada.

Employees610
IPOJul 12, 2016
Beta0.94
ATR, 14d0.13
Rel volume0.98
Short float2.29%
Insider own50.51%
Inst own14.64%

Snapshot

6 groups

Valuation

Index-
Market Cap1.26B
Enterprise Value573.20M
Income57.83M
Sales206.20M
Book/sh2.92
Cash/sh2.03
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees610
IPOJul 12, 2016

Ratios

P/E22.39
Forward P/E18.75
PEG-
P/S6.13
P/B1.18
P/C1.70
P/FCF19.47
EV/EBITDA22.50
EV/Sales2.78
Quick Ratio11.91
Current Ratio12.71
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortYes / Yes

Earnings

EPS (ttm)0.15
EPS next Y0.18
EPS next Q0.04
EPS this Y1020.00%
EPS next Y0.00%
EPS next 5Y-
EPS past 3/5Y61.97% 34.75%
Sales past 3/5Y19.11% 25.70%
EPS Y/Y TTM62.78%
Sales Y/Y TTM55.79%
EPS Q/Q-44.81%
Sales Q/Q74.61%
EarningsNov 05 BMO
EPS/Sales Surpr.20.12% 24.05%

Ownership

Insider Own50.51%
Insider Trans0.00%
Inst Own14.64%
Inst Trans-0.96%
ROA4.87%
ROE5.37%
ROIC5.39%
Gross Margin45.84%
Oper. Margin4.85%
Profit Margin28.04%
SMA201.81%
SMA504.07%
SMA20019.47%
Trades-

Technical

Shs Outstand367.53M
Shs Float181.35M
Short Float2.29%
Short Ratio3.79
Short Interest4.15M
52W High3.91 -11.76%
52W Low2.28 51.32%
Volatility5.46% 3.64%
ATR (14)0.13
RSI (14)53.61
Beta0.94
Rel Volume0.98
Avg Volume1.10M
Volume1,072,952

Performance

Perf Week-1.71%
Perf Month7.81%
Perf Quarter9.18%
Perf Half Y26.37%
Perf YTD31.18%
Perf Year36.90%
Perf 3Y67.48%
Perf 5Y-39.26%
Perf 10Y307.37%
Recom1.40
Target Price4.31
Prev Close3.41
Price3.45
Change %1.17%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jan 27, 2026InitiatedCCanaccord GenuityBuy
Nov 02, 2022InitiatedBBernsteinMkt Perform$3-13.0%
Jul 28, 2022UpgradeCCanaccord GenuityHold → Buy
May 11, 2022UpgradeCCIBCNeutral → Sector Outperform
Mar 22, 2022UpgradeBBarclaysUnderweight → Equal Weight
Jan 27, 2022UpgradeJJefferiesUnderperform → Hold$5.54 → $3.24-6.1%
Nov 18, 2021ResumedBBofA SecuritiesUnderperform$5+44.9%
Apr 28, 2021ResumedBBofA SecuritiesUnderperform$7.50+117.4%
Feb 22, 2021DowngradeCCIBCSector Outperform → Neutral$8 → $12.50+262.3%
Jun 24, 2020UpgradeRRaymond JamesMkt Perform → Outperform

Peers

Mkt cap
TickerCompanyMkt cap
CGCCanopy Growth Corp256.13M
TLRYTilray Brands Inc385.73M
OGIOrganigram Global Inc120.38M
ACBAurora Cannabis Inc331.99M
TRLVTrulieve Cannabis Corp2.16B
GLASGlass House Brands Inc144.79M
INCRIntercure Ltd50.71M
SNDLSNDL Inc345.52M
VFFVillage Farms International Inc329.04M
HITIHigh Tide Inc225.52M

Insider trading

latest 14 of 29
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Doucet Terrence Gregory JosephSee RemarksMay 12 '26Option Exercise0.0010,5970115,787May 14 04:58 PM
Wagner AdamSee remarksMay 12 '26Option Exercise0.0010,3670103,987May 14 04:58 PM
Buggy ShannonSee RemarksMay 12 '26Option Exercise0.0020,6220187,501May 14 04:57 PM
Kenost Jared MatthewSee RemarksMay 12 '26Option Exercise0.009,412046,675May 14 04:56 PM
Weigensberg AryeSee RemarksMay 10 '26Option Exercise0.003,1180211,555May 12 05:20 PM
Wagner AdamSee remarksMay 10 '26Option Exercise0.0020,470093,620May 12 05:20 PM
Kenost Jared MatthewSee RemarksMay 10 '26Option Exercise0.0012,649039,141May 12 05:20 PM
Shlimak AnnaSee RemarksMar 19 '26Option Exercise0.0028,4290368,362Mar 20 05:11 PM
Doucet Terrence Gregory JosephSee RemarksMar 15 '26Option Exercise0.0023,8970117,466Mar 17 05:12 PM
Weigensberg AryeSee RemarksMar 15 '26Option Exercise0.0024,2360208,437Mar 17 05:11 PM
GORENSTEIN MICHAEL RYANSee remarks belowMar 15 '26Option Exercise0.00324,540013,340,723Mar 17 05:11 PM
Shlimak AnnaSee RemarksMar 15 '26Option Exercise0.0045,2260356,287Mar 17 05:10 PM
JACOBSON JEFFREY DAVIDChief Growth OfficerMar 15 '26Option Exercise0.0059,1910507,233Mar 17 05:09 PM
Buggy ShannonSee RemarksMar 15 '26Option Exercise0.0020,9380176,081Mar 17 05:09 PM

Held by

AUM
TickerCompanyAUM
DFISDimensional International Small Cap ETFAUM: 5.82B
DFICDimensional International Core Equity 2 ETFAUM: 15.45B
ONEQFidelity Nasdaq Composite Index ETFAUM: 10.35B
DFAXDimensional World ex U.S. Core Equity 2 ETFAUM: 12.02B
GWXState Street SPDR S&P International Small Cap ETFAUM: 906.57M
DISVDimensional International Small Cap Value ETFAUM: 5.11B
DFAIDimensional International Core Equity Market ETFAUM: 18.32B
DXIVDimensional International Vector Equity ETFAUM: 241.45M

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-050.0400.0330.04063.4551.153
2026Q22026-08-060.0900.0100.08653.0144.202
2026Q12026-05-110.0400.0050.03645.2142.202
2025Q42026-02-260.0000.017-0.00544.5338.723
2025Q32025-11-060.070-0.06736.3437.30-
2025Q22025-08-07-0.100-0.100-0.10333.4633.461
2025Q12025-05-080.0200.0100.01633.6231.721
2024Q42025-02-270.1100.0000.11330.5334.912
2024Q32024-11-120.0200.0050.02234.2630.602
2024Q22024-08-08-0.020-0.003-0.02327.7626.093
2024Q12024-05-09-0.010-0.010-0.00625.2923.853
2023Q42024-02-29-0.120-0.043-0.11824.4825.733
2023Q32023-11-080.000-0.018-0.00424.8120.014
2023Q22023-08-08-0.010-0.030-0.02219.0222.325
2023Q12023-05-09-0.050-0.040-0.05020.1424.066
2022Q42023-02-28-0.210-0.053-0.20822.8922.204

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY3.3301.6893.33223.7534.33
2020FY-0.2100.029-0.20846.7243.79
2021FY-1.070-0.275-1.06974.4471.57
2022FY-0.450-0.270-0.44791.9094.11
2023FY-0.180-0.106-0.19491.7188.75
2024FY0.110-0.0630.107118.98122.03
2025FY-0.020-0.003-0.020146.59138.84
2026FY-0.184--222.84
2027FY-0.184--283.62
2028FY-0.188--306.74
2029FY-0.246--334.65
2030FY-0.190--312.36

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0542164.5757.0069.00
2026Q4S2026-10-2142063.3357.0066.90
2026Q4S2026-10-1541060.8053.7066.90
2026Q4S2026-10-0940059.5053.7066.90
2026Q4S2026-09-2530060.3353.7066.90
2026Q4S2026-09-2430060.3253.7066.85
2026Q4S2026-08-0730060.3353.7066.90
2026Q4S2026-08-0630060.3253.7066.85
2026Q4S2026-05-1230060.2053.7066.40
2026Q4S2026-05-1132160.2053.7066.40
2026Q4S2026-05-0132160.0053.7065.80
2026Q4S2026-02-2732159.9653.7065.80
2026Q4S2026-02-2632159.9553.7065.78
2026Q4S2026-02-2330059.0156.8061.40

Estimate history

EPS, annual0.011-0.1263.332-0.208-1.069-0.447-0.1940.107-0.0250.1541
Period201720182019202020212022202320242025TTM
EPS, quarterly0.0220.1130.016-0.1030.067-0.0050.0360.0860.037
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1.25812.12123.7546.71974.43586.74987.241117.615146.587206.2
Period201720182019202020212022202320242025TTM
Sales, quarterly34.26430.30132.26233.45536.33944.53145.2153.00763.45
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual149.361178.72348.817360.253374.953380.575381.299382.531381.593367.528
Period201720182019202020212022202320242025MRQ
Shares, quarterly382.295382.531385.406383.807382.893381.593376.259370.726367.528
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue206.20146.59117.6187.2486.7574.4446.7223.7512.12
Cost of Goods Sold Incl. D&A111.6985.9596.1280.3877.2896.4575.4243.446.88
Gross Profit94.5160.6421.506.879.47-22.02-28.70-19.695.24
Selling, General and Administrative Excl. Other84.5078.1780.0186.78113.86174.90150.6496.0926.59
Research and Development5.354.454.235.8413.1323.3320.3712.161.81
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income10.01-17.53-58.52-79.91-104.39-196.92-179.35-115.78-21.34
Interest Expense0.000.000.000.000.000.000.0432.210.00
Unusual Expense6.465.195.5940.3754.37203.70-89.25-1,271.490.00
Net Income Before Taxes60.19-17.1236.59-73.67-121.00-390.82-68.761,167.95-21.09
Income Taxes-8.52-14.19-3.44-3.2334.18-0.431.350.000.00
Consolidated Net Income68.71-2.9340.02-70.44-155.18-396.70-74.621,165.94-21.82
Net Income From Continuing Operations57.83-9.4541.08-69.85-155.18-395.61-72.491,166.87-21.64
Net Income57.83-9.4541.08-73.85-168.57-396.11-73.141,166.51-21.64
EPS (Recurring)0.17-0.020.12-0.12-0.35-0.68-0.390.74-0.13
EPS (Basic, Before Extraordinaries)0.15-0.020.11-0.19-0.45-1.07-0.213.76-0.13
EPS (Diluted)0.15-0.020.11-0.19-0.45-1.07-0.213.33-0.13
EBITDA25.48-3.30-49.18-72.04-91.27-181.52-172.30-111.87-19.40
Non-Operating Income (Expense)56.655.60100.6946.6137.769.8021.3744.440.25
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense5.085.57626.406.4411.867.4611.298.545.99
Price To Earnings Ratio22.3922.39-----1.93-
Price To Sales Ratio5.956.876.599.1711.0319.6252.22110.98149.64
Gross Margin45.8441.3718.287.8710.92-29.58-61.44-82.8943.26
Operating Margin4.85-11.96-49.75-91.60-120.34-264.55-383.88-487.49-176.07
Net Margin28.04-6.4434.93-84.64-194.31-532.15-156.554,911.60-178.50
Shares Outstanding367.53381.59382.53381.30380.58374.95360.25348.82178.72
Market Capitalization1,264.331,264.33772.24796.53961.311,457.482,471.942,636.671,856.84

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue63.4553.0145.2144.5336.3433.4532.2630.30
Cost of Goods Sold Incl. D&A31.5324.9426.4828.7418.3619.8219.0219.96
Gross Profit31.9228.0718.7315.7917.9813.6413.2410.34
Selling, General and Administrative Excl. Other23.0120.4720.1820.8423.0018.1916.7621.71
Research and Development1.341.221.411.381.350.930.791.03
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income8.917.60-1.46-5.05-5.03-4.56-3.52-11.37
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense-0.800.310.486.480.251.410.51-0.35
Net Income Before Taxes18.7235.7118.14-12.3927.01-39.017.2745.95
Income Taxes0.900.052.43-11.90-1.32-0.53-0.462.00
Consolidated Net Income17.8335.6615.71-0.4928.32-38.487.7243.94
Net Income From Continuing Operations13.8032.0913.75-1.8225.96-39.716.1243.73
Net Income13.8032.0913.75-1.8225.96-39.716.1243.73
EPS (Recurring)0.040.090.040.010.07-0.100.020.11
EPS (Basic, Before Extraordinaries)0.040.090.04-0.000.07-0.100.020.11
EPS (Diluted)0.040.090.04-0.000.07-0.100.020.11
EBITDA13.6210.982.27-1.40-1.49-0.35-0.68-8.84
Non-Operating Income (Expense)9.0128.4220.08-0.8632.28-33.0411.2956.96
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.821.231.040.991.841.091.65157.46
Price To Earnings Ratio22.39--28.1958.5314.9617.08-
Price To Sales Ratio5.955.796.046.858.055.665.596.60
Gross Margin50.3152.9641.4235.4549.4740.7641.0334.13
Operating Margin14.0414.35-3.22-11.34-13.83-13.62-10.90-37.51
Net Margin21.7660.5330.42-4.0871.43-118.7018.98144.32
Shares Outstanding367.53370.73376.26381.59382.89383.81385.41382.53
Market Capitalization1,264.331,038.78951.421,007.011,064.57736.15692.38772.24

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments831.79858.80861.53877.721,004.661,289.791,506.0423.937.35
Short Term Receivables57.2029.7735.8837.7733.2926.0416.535.793.65
Inventories46.7533.1530.5037.5632.8044.0038.047.399.69
Other Current Assets8.3414.395.417.118.9712.3412.642.84-
Total Current Assets944.09936.11933.31960.161,079.721,372.171,573.2639.9421.31
Net Property, Plant & Equipment147.29134.5860.8262.8382.95197.38166.49126.0344.83
Total Investments and Advances7.662.8154.7489.75135.2619.7019.997.954.11
Long-Term Note Receivable20.8515.5369.0472.3480.6487.1944.970.00-
Intangible Assets75.3774.7122.1427.7419.18249.24285.739.5510.37
Deferred Tax Assets1.892.570.23----4.134.59
Other Assets0.000.000.000.190.000.000.000.0010.32
Total Assets1,197.141,166.311,140.271,213.011,397.741,925.682,090.44183.4785.22
Short Term Debt Incl. Current Port. of LT Debt0.341.020.991.332.711.320.430.030.00
Accounts Payable11.6416.9712.1311.1611.2242.1035.3033.24-
Income Tax Payable16.1011.8411.7632.96-----
Other Current Liabilities20.1119.8616.5222.6740.44163.41297.160.006.29
Total Current Liabilities48.1949.7041.4068.1254.37206.83332.8933.276.29
Long Term Debt1.170.991.562.557.098.496.680.094.14
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities4.093.560.18-0.08--5.485.72
Other Liabilities0.731.071.001.381.912.191.841.576.44
Total Liabilities54.1855.3344.1472.0563.46217.51341.4134.9216.29
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,093.901,064.061,099.571,143.881,337.241,711.361,749.88148.4568.93
Total Shareholders Equity1,093.901,064.061,099.571,143.881,337.241,711.361,749.88148.4568.93
Accumulated Minority Interest49.0646.92-3.45-2.92-2.97-3.20-0.850.100.00
Total Equity1,142.961,110.981,096.121,140.961,334.281,708.171,749.03148.5568.93
Total Liabilities & Stockholders Equity1,197.141,166.311,140.271,213.011,397.741,925.682,090.44183.4785.22
Book Value Per Share2.872.782.883.013.574.755.020.830.46
Tangible Book Value Per Share2.672.592.832.933.524.064.200.780.39
Full-Time Employees610459356447628667633297107
Price to Book Ratio1.180.710.710.801.101.461.5311.9920.42
Return on Assets-0.803.56-5.94-11.89-23.81-3.61102.63-16.102.25
Return on Equity-0.883.80-6.23-12.51-25.95-4.19122.94-19.912.78
Return on Invested Capital-0.863.86-6.71-14.70-29.46-4.2566.41-14.572.63
Quick Ratio18.6218.1721.8113.5419.256.424.610.981.85
Current Ratio19.5918.8422.5414.1019.866.634.731.203.39

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income68.02-2.9340.02-74.55-168.73-397.20-75.271,165.57-21.82
Depreciation15.2114.239.347.8713.1215.407.053.911.94
Other Funds (Non Cash)-10.9348.98-30.2051.9651.39230.19-40.29-1,245.558.56
Funds from Operations72.3060.2819.15-14.73-104.22-151.61-108.51-76.07-11.32
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital7.89-34.41-0.31-26.4715.66-2.01-33.94-54.213.66
Income Taxes Payable6.01-0.01-0.09-33.1034.21----
Cash from Operating Activities80.2025.8718.84-41.19-88.56-153.62-142.46-130.27-7.66
Capital Expenditures-15.52-26.06-13.15-3.42-5.03-12.26-35.39-38.95-88.59
Net Assets From Acquisitions0.000.000.000.000.000.00-1.02-224.300.00
Sale of Fixed Assets and Businesses2.852.855.990.000.002.770.000.000.00
Purchase or Sale of Investments-389.35-53.35182.31-58.582.74-19.41100.19-297.10-5.18
Purchase of Investments-434.01-58.41-8.76-608.25-271.38-234.710.00-316.72-5.93
Sale Or Maturity of Investments44.665.06191.07549.67274.12215.30100.1919.610.75
Other Uses13.510.000.000.000.000.00-44.65-43.340.00
Other Sources0.540.000.000.860.070.000.000.420.00
Cash from Investing Activities-387.96-76.56175.15-61.14-2.23-28.9019.13-603.27-93.77
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-46.03-9.740.000.000.000.020.1264.78110.55
Repurchase of Common Pref Stock-46.03-9.740.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.020.1264.78110.55
Proceedsfrom Stock Options0.000.000.000.000.000.000.0063.33107.93
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.00-15.5611.58
Change in Long Term Debt0.000.000.000.000.000.000.00-15.9711.58
Issuance of Long Term Debt0.000.000.000.000.000.000.000.0011.58
Reduction of Long Term Debt0.000.000.000.000.000.000.00-15.970.00
Net Financing Active Other Cash Flow-9.30-10.16-1.23-1.03-2.90-13.46-2.151,808.64-0.02
Other Financing Activities Uses-9.30-10.16-1.23-1.03-2.90-13.46-2.15-0.92-0.02
Cash from Financing Activities-55.34-19.91-1.23-1.03-2.90-13.44-4.451,856.94122.11
Exchange Rate Effect-1.133.59-3.258.01-28.644.916.1052.37-4.09
Net Change in Cash-364.23-67.01189.51-95.35-122.33-191.05-121.671,175.7716.60
Free Cash Flow64.940.156.43-43.70-92.02-164.76-173.87-168.94-95.97
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow18.906,759.08120.45------
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments745.00797.02821.86831.79824.17834.42
Short Term Receivables53.5157.0452.3757.2038.1739.38
Inventories54.5252.7048.6846.7548.1742.14
Other Current Assets6.285.274.978.3411.6411.21
Total Current Assets859.31912.03927.88944.09922.15927.15
Net Property, Plant & Equipment145.24142.82143.41147.29147.06151.92
Total Investments and Advances101.0534.535.207.6611.442.25
Intangible Assets71.6472.2073.9875.3775.2477.48
Deferred Tax Assets3.280.910.841.890.102.66
Other Assets0.000.000.000.000.000.00
Total Assets1,198.011,179.861,172.111,197.141,178.411,175.23
Short Term Debt Incl. Current Port. of LT Debt0.300.160.170.340.580.82
Accounts Payable15.7717.4210.2811.6410.8712.14
Income Tax Payable5.933.551.3716.100.000.01
Other Current Liabilities45.5935.2330.6020.1129.6224.64
Total Current Liabilities67.5956.3642.4248.1941.0737.61
Long Term Debt0.911.131.141.171.171.19
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities4.894.923.984.093.435.54
Other Liabilities0.000.000.750.730.700.68
Total Liabilities73.4062.4148.3054.1846.3645.02
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,071.941,068.671,073.661,093.901,082.501,082.29
Total Shareholders Equity1,071.941,068.671,073.661,093.901,082.501,082.29
Accumulated Minority Interest52.6748.7750.1549.0649.5547.92
Total Equity1,124.611,117.441,123.811,142.961,132.051,130.21
Total Liabilities & Stockholders Equity1,198.011,179.861,172.111,197.141,178.411,175.23
Book Value Per Share2.922.882.852.872.832.82
Tangible Book Value Per Share2.722.692.662.672.632.62
Full-Time Employees---610--
Price to Book Ratio1.180.970.880.930.990.69
Return on Assets4.875.94-0.16-0.803.061.63
Return on Equity5.376.51-0.17-0.883.341.73
Return on Invested Capital1.293.001.28-0.172.40-3.67
Quick Ratio11.9115.2520.7318.6221.2823.53
Current Ratio12.7116.1821.8719.5922.4524.65

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income17.3435.4215.71-0.4628.83-39.02
Depreciation4.623.343.733.523.574.33
Other Funds (Non Cash)-0.34-16.63-8.8214.86-13.0545.40
Funds from Operations21.6322.1310.6217.9219.3410.70
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital12.151.720.28-6.25-5.83-7.87
Income Taxes Payable2.432.201.39-0.00-0.010.00
Cash from Operating Activities33.7823.8510.9011.6713.512.83
Capital Expenditures-9.82-1.76-1.97-1.96-4.61-4.18
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.002.850.000.00
Purchase or Sale of Investments-63.17-358.5140.00-7.66-5.09-0.71
Purchase of Investments-62.94-358.330.00-12.74-5.09-0.71
Sale Or Maturity of Investments-0.23-0.1940.005.070.000.00
Other Uses0.000.000.0013.51-13.510.00
Other Sources-0.023.460.00-2.90-0.012.91
Cash from Investing Activities-73.02-356.8138.033.84-23.23-1.98
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-9.12-15.98-16.73-4.21-1.88-3.68
Repurchase of Common Pref Stock-9.12-15.98-16.73-4.21-1.88-3.68
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.03-4.72-1.54-3.070.01-4.20
Other Financing Activities Uses0.03-4.72-1.54-3.070.01-4.20
Cash from Financing Activities-9.10-20.70-18.27-7.27-1.87-7.87
Exchange Rate Effect-1.250.34-0.600.391.332.48
Net Change in Cash-49.59-353.3330.068.63-10.26-4.54
Free Cash Flow23.9522.139.029.849.00-1.34
Price to Free Cash Flow18.9020.7336.306,729.01--

Revenue breakdown

Cannabis Extracts2024: 29.17M 2025: 37.70M
Cannabis Flower2024: 87.91M 2025: 108.48M
Product and Service, Other2024: 535.00K 2025: 411.00K
Canada2024: 82.44M 2025: 90.33M
Israel2024: 28.37M 2025: 41.80M
Other Countries2024: 6.81M 2025: 14.46M
Total Medicinal Chemicals & Botanical Products revenue2024: 117.62M 2025: 146.59M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.29%4.2M181.4M1.13M
2026-10-152.17%4.0M182.3M1.13M
2026-09-301.85%3.4M182.3M1.13M
2026-09-151.78%3.3M182.3M1.15M
2026-08-311.76%3.2M184.9M1.22M
2026-08-141.83%3.4M184.9M1.21M
2026-07-311.85%3.4M184.9M1.15M
2026-07-151.87%3.5M187.5M1.50M
2026-06-301.67%3.1M187.5M1.50M
2026-06-151.97%3.7M187.5M1.50M
2026-05-291.86%3.5M190.2M1.48M
2026-05-152.11%4.0M190.4M1.49M
2026-04-302.30%4.4M193.2M1.40M
2026-04-152.36%4.6M193.2M1.17M
2026-03-311.95%3.8M196.1M1.25M
2026-03-132.12%4.2M196.1M1.75M
2026-02-271.96%3.8M196.1M2.25M
2026-02-131.76%3.5M198.1M2.25M
2026-01-301.76%3.5M198.1M2.27M
2026-01-152.29%4.5M198.1M2.20M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.801.100.952.6481275.000.902-0.0100.001
call5.000.000.050.031.7983020.000.118-0.0110.001
call7.500.000.250.003.0430.000.000.080-0.0140.001
put2.500.000.050.031.7964.000.00-0.098-0.0090.001
put5.001.201.951.333.88624.000.00-0.882-0.0100.001
put7.503.504.700.006.7360.000.00-0.920-0.0130.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-10-204Statement of changes in beneficial ownership of securities2026-10-16SEC
2026-10-203Initial statement of beneficial ownership of securities2026-10-15SEC
2026-10-158-KCurrent report2026-10-15SEC
2026-09-118-KCurrent report2026-09-08SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-078-K/A2026-06-18SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-06-303Initial statement of beneficial ownership of securities2026-06-18SEC
2026-06-228-KCurrent report2026-06-18SEC
2026-05-29SDSpecialized Disclosure ReportSEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-124Statement of changes in beneficial ownership of securities2026-05-10SEC
2026-05-124Statement of changes in beneficial ownership of securities2026-05-10SEC
2026-05-124Statement of changes in beneficial ownership of securities2026-05-10SEC
2026-05-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-118-KCurrent report2026-05-08SEC
2026-04-24DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-24DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342025-12-31SEC
2026-03-204Statement of changes in beneficial ownership of securities2026-03-19SEC
2026-03-174Statement of changes in beneficial ownership of securities2026-03-15SEC
2026-03-174Statement of changes in beneficial ownership of securities2026-03-15SEC
2026-03-174Statement of changes in beneficial ownership of securities2026-03-15SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
D. E. Shaw & Co., Inc.2.37%
Chescapmanager LLC2.13%
Tidal Investments LLC1.01%
DIMENSIONAL FUND ADVISORS LP0.87%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP0.53%
MACKENZIE FINANCIAL CORP0.51%
RENAISSANCE TECHNOLOGIES LLC0.47%
CIBC WORLD MARKET INC.0.35%
MMCAP International Inc. SPC0.27%
CITADEL ADVISORS LLC0.25%

Funds

Fund% owned
Amplify Alternative Harvest ETF0.97%
INTERNATIONAL CORE EQUITY 2 PORTFOLIO0.23%
The Canadian Small Company Series0.20%
iShares Core MSCI Total International Stock ETF0.18%
AdvisorShares Pure Cannabis ETF0.13%
USA Mutuals Vice Fund0.13%
Dimensional International Core Equity 2 ETF0.10%
iShares Core MSCI International Developed Markets ETF0.09%
Fidelity Nasdaq Composite Index ETF0.06%
Dimensional World ex. U.S. Core Equity 2 ETF0.06%

OakChart. CRON. Cached 15 minutes.